Everand Logo

Welcome to Everand!

  • STAT

    Diabetes-coaching startup Livongo files to go public in a test for health tech

    Livongo, a startup that monitors and coaches patients with chronic diseases, filed papers to launch its initial public offering, in what is seen as a litmus test for health-tech companies.
    by Casey Ross and Rebecca Robbins Jun 28, 2019 2 minutes
    Source: John Locher/AP

    Livongo, a startup that monitors and coaches patients with chronic diseases, on Friday filed papers to launch its initial public offering, in what is seen as a litmus test for health-tech companies seeking to translate early growth into value in the public markets.

    The offering is expected to be among the first for a new generation of slick and savvy venture-backed companies in the U.S. digital health sector, which hasn’t produced

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
    The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

    Related Books & Audiobooks